Senators Collins, King Join Bipartisan Group in Introducing Legislation to Combat Rising Prescription Drug Prices

Washington, D.C. – U.S. Senators Susan Collins (R-Maine) and Angus King (I-Maine) joined a bipartisan group in introducing legislation to combat anticompetitive practices used by some brand-name drug companies to block entry of lower-cost generic drugs. 


The Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act would deter pharmaceutical companies from blocking cheaper generic alternatives from entering the marketplace. 



Senator Collins Joins Bipartisan Group in Introducing Bill to Enforce Commerce Deal with Chinese Telecom Firm ZTE

Washington, D.C. – U.S. Senator Susan Collins, a member of the Senate Intelligence Committee, joined a bipartisan group of Senators in introducing legislation to enforce full compliance by ZTE with all probationary conditions in the Commerce Department’s July 2018 deal.  The deal lifted a denial order, banning the export of U.S. parts and components to ZTE for seven years.  If the Commerce Secretary cannot regularly certify ZTE’s full compliance with the deal and with relevant U.S.